Open Access
Open access
volume 276 issue 5309 pages 111-113

The Receptor for the Cytotoxic Ligand TRAIL

Guohua Pan 1
Karen O'Rourke 1
Arul M. Chinnaiyan 1
REINER GENTZ 2
Reinhard Ebner 2
Jian Ni 2
Vishva M. Dixit 1
Publication typeJournal Article
Publication date1997-04-04
scimago Q1
wos Q1
SJR10.416
CiteScore48.4
Impact factor45.8
ISSN00368075, 10959203
Multidisciplinary
Abstract

TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. The human receptor for TRAIL was found to be an undescribed member of the TNF-receptor family (designated death receptor-4, DR4) that contains a cytoplasmic “death domain” capable of engaging the cell suicide apparatus but not the nuclear factor kappa B pathway in the system studied. Unlike Fas, TNFR-1, and DR3, DR4 could not use FADD to transmit the death signal, suggesting the use of distinct proximal signaling machinery. Thus, the DR4-TRAIL axis defines another receptor-ligand pair involved in regulating cell suicide and tissue homeostasis.

Found 
Found 

Top-30

Journals

10
20
30
40
50
60
70
Journal of Biological Chemistry
70 publications, 4.95%
Journal of Immunology
47 publications, 3.33%
Oncogene
36 publications, 2.55%
Cell Death and Differentiation
26 publications, 1.84%
Biochemical and Biophysical Research Communications
21 publications, 1.49%
Cancer Research
20 publications, 1.42%
Cancer Letters
19 publications, 1.34%
Blood
17 publications, 1.2%
Apoptosis : an international journal on programmed cell death
16 publications, 1.13%
Oncotarget
15 publications, 1.06%
International Journal of Molecular Sciences
14 publications, 0.99%
PLoS ONE
14 publications, 0.99%
International Journal of Cancer
14 publications, 0.99%
FEBS Letters
12 publications, 0.85%
Journal of Virology
12 publications, 0.85%
Scientific Reports
11 publications, 0.78%
Vitamins and Hormones
11 publications, 0.78%
Molecular Cancer Therapeutics
11 publications, 0.78%
Immunity
10 publications, 0.71%
Oncology Reports
10 publications, 0.71%
Cancers
10 publications, 0.71%
European Journal of Immunology
10 publications, 0.71%
Proceedings of the National Academy of Sciences of the United States of America
10 publications, 0.71%
Journal of Experimental Medicine
10 publications, 0.71%
British Journal of Cancer
9 publications, 0.64%
Gynecologic Oncology
9 publications, 0.64%
Journal of Cellular Biochemistry
9 publications, 0.64%
Clinical Cancer Research
9 publications, 0.64%
Cell Death and Disease
8 publications, 0.57%
10
20
30
40
50
60
70

Publishers

50
100
150
200
250
300
Elsevier
298 publications, 21.09%
Springer Nature
289 publications, 20.45%
Wiley
147 publications, 10.4%
American Society for Biochemistry and Molecular Biology
71 publications, 5.02%
MDPI
60 publications, 4.25%
The American Association of Immunologists
48 publications, 3.4%
Taylor & Francis
46 publications, 3.26%
American Association for Cancer Research (AACR)
43 publications, 3.04%
Ovid Technologies (Wolters Kluwer Health)
35 publications, 2.48%
Spandidos Publications
24 publications, 1.7%
American Society for Microbiology
22 publications, 1.56%
Oxford University Press
18 publications, 1.27%
American Society of Hematology
17 publications, 1.2%
Public Library of Science (PLoS)
16 publications, 1.13%
Impact Journals
15 publications, 1.06%
Mary Ann Liebert
14 publications, 0.99%
Hindawi Limited
13 publications, 0.92%
Cold Spring Harbor Laboratory
13 publications, 0.92%
Frontiers Media S.A.
11 publications, 0.78%
American Chemical Society (ACS)
11 publications, 0.78%
SAGE
10 publications, 0.71%
Proceedings of the National Academy of Sciences (PNAS)
10 publications, 0.71%
Rockefeller University Press
10 publications, 0.71%
American Association for the Advancement of Science (AAAS)
7 publications, 0.5%
IMR Press
7 publications, 0.5%
Baishideng Publishing Group
6 publications, 0.42%
Royal Society of Chemistry (RSC)
6 publications, 0.42%
S. Karger AG
4 publications, 0.28%
Portland Press
4 publications, 0.28%
50
100
150
200
250
300
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.4k
Share
Cite this
GOST |
Cite this
GOST Copy
Pan G. et al. The Receptor for the Cytotoxic Ligand TRAIL // Science. 1997. Vol. 276. No. 5309. pp. 111-113.
GOST all authors (up to 50) Copy
Pan G., O'Rourke K., Chinnaiyan A. M., GENTZ R., Ebner R., Ni J., Dixit V. M. The Receptor for the Cytotoxic Ligand TRAIL // Science. 1997. Vol. 276. No. 5309. pp. 111-113.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1126/science.276.5309.111
UR - https://doi.org/10.1126/science.276.5309.111
TI - The Receptor for the Cytotoxic Ligand TRAIL
T2 - Science
AU - Pan, Guohua
AU - O'Rourke, Karen
AU - Chinnaiyan, Arul M.
AU - GENTZ, REINER
AU - Ebner, Reinhard
AU - Ni, Jian
AU - Dixit, Vishva M.
PY - 1997
DA - 1997/04/04
PB - American Association for the Advancement of Science (AAAS)
SP - 111-113
IS - 5309
VL - 276
PMID - 9082980
SN - 0036-8075
SN - 1095-9203
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1997_Pan,
author = {Guohua Pan and Karen O'Rourke and Arul M. Chinnaiyan and REINER GENTZ and Reinhard Ebner and Jian Ni and Vishva M. Dixit},
title = {The Receptor for the Cytotoxic Ligand TRAIL},
journal = {Science},
year = {1997},
volume = {276},
publisher = {American Association for the Advancement of Science (AAAS)},
month = {apr},
url = {https://doi.org/10.1126/science.276.5309.111},
number = {5309},
pages = {111--113},
doi = {10.1126/science.276.5309.111}
}
MLA
Cite this
MLA Copy
Pan, Guohua, et al. “The Receptor for the Cytotoxic Ligand TRAIL.” Science, vol. 276, no. 5309, Apr. 1997, pp. 111-113. https://doi.org/10.1126/science.276.5309.111.